HAUPPAUGE, N.Y.–(HISPANIC PR WIRE – BUSINESS WIRE)–April 16, 2003–Curative Health Services, Inc. (Nasdaq:CURE)
While other children enjoyed summer vacations with their families, Ivan Escobar was in the emergency room once again fighting for his life.
For Ivan, there was no possibility of growing up in a carefree environment. He had lost his brothers to hemophilia and he had the disease as well.
This week, on April 17, hemophilia organizations around the globe will mark World Hemophilia Day as an opportunity to increase awareness of the disease. There are an estimated 25,000 people living with hemophilia in the US alone.
Ivan Escobar, now an adult, will mark that date too. But for him, it will also bring back memories of living in El Salvador where access to the quality care and products required to keep hemophilia patients healthy were not always available.
The complications of not having access to the blood clotting factor required by hemophilia patients to help prevent and control bleeding can be very serious. Losing two of their sons was a turning point for the Escobar family. They immigrated to the US, where they had access to the unique care that the disease requires.
Hemophilia is a genetic disease. The person lacks an essential protein that prevents the blood from clotting normally. Parents are taught to infuse their child with the missing clotting factors at a very early age, resulting in quicker treatment of bleeding events, thus reducing long term complications. Without proper treatment, people living with hemophilia suffer bleeds into joints and muscles resulting in severe pain and crippling. In severe situations, bleeding episodes into internal organs or the central nervous system are frequently fatal.
“The disease knows no boundary or border, nevertheless many countries need more access to special pharmacy products as well as education in care and prevention,” said Escobar. “Hemophilia is truly a global problem.”
Ivan and his family now live in Southern California, where he works closely with Hemophilia support groups. As a member of the hemophilia community and a patient advocate, Ivan receives one-on-one care through specialty pharmacy and home care services. These services are provided by Apex Therapeutic Care, Inc., a subsidiary of Curative Health Services, Inc. Experts insist that this one-on-one care is the cornerstone of the proactive and successful treatment of this chronic disease.
“Many enhancements in blood factor products and preventive treatment modalities have been introduced in recent years, which have resulted in less hospitalization, better overall health and longer life spans,” Escobar says. “Patients now show increased productivity. And that is important.”
The one-on-one care, which Escobar advocates, also has a positive effect on state health expenditures. At a recent legislative hearing, analysts pointed out that the reduction in episodic hospitalization and other high cost healthcare incidents related to hemophilia, actually bring about a lower overall cost to the healthcare system. High quality specialty pharmacy and home care services such as those advocated by Escobar are, they say, integral to this success.
For more information on hemophilia, visit http://www.curative.com
About Curative Health Services
Curative Health Services delivers superior clinical outcomes and unmatched patient satisfaction for patients experiencing serious medical conditions through two unique business units.
Curative’s Specialty Pharmacy Services business unit provides services to help patients manage the health care process, and offers related pharmacy products to patients for chronic and critical disease states including Hemophilia, Immune System Disorders, Respiratory Syncytial Virus (RSV), Multiple Sclerosis and Rheumatoid Arthritis.
Curative’s Specialty Healthcare Services (SHS) business unit is an industry leader in chronic wound care management, consistently achieving an outcome success rate of more than 85 percent. SHS provides a broad continuum of services to health care providers through a nationwide network. This national network of hospital-based Wound Care Center(R) programs has offered comprehensive treatment to over 375,000 patients, achieving more than a 94 percent patient satisfaction rate.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such differences include, but are not limited to, the termination or non-renewal of a material number of contracts, an inability to obtain new contracts, changes in the government regulations relating to the Company’s Specialty Healthcare Services or Specialty Pharmacy Services business units, changes in the regulations governing third party reimbursements for the Company’s services, manufacturing shortages of products sold by Curative’s Specialty Pharmacy Services business unit, and the other risks and uncertainties detailed in the Company’s filings with the Securities and Exchange Commission. Readers of this release are referred to the Company’s Annual Report on Form 10K for the year ended December 31, 2002, for further discussion of these and other factors that could affect future results.
Curative Health Services
Anne Bruce, 800/966-5656 ext.2339